Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo, M. Uchida, Kumiko Tanaka, et al.
Inflammation and Regeneration (2020) Vol. 40, Iss. 1
Open Access | Times Cited: 627

Showing 26-50 of 627 citing articles:

The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease
Elisa Avolio, Michele Carrabba, Rachel Milligan, et al.
Clinical Science (2021) Vol. 135, Iss. 24, pp. 2667-2689
Open Access | Times Cited: 82
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
Ali Attiq, Lui Jin Yao, Sheryar Afzal, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108255-108255
Open Access | Times Cited: 80
Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
Anna Stasiłowicz-Krzemień, Anna Tomala, Irma Podolak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 778-778
Open Access | Times Cited: 75
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
Ali A. Rabaan, Shamsah H. Al-Ahmed, Mohammed Garout, et al.
Pathogens (2021) Vol. 10, Iss. 5, pp. 565-565
Open Access | Times Cited: 73
Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
Wei Qiu, Lin Hua, Rongguo Wei, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: An Observational Multicenter Study
Nicolas Hoertel, Marina Sánchez‐Rico, Erich Gulbins, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 6, pp. 1498-1511
Open Access | Times Cited: 67
Sex differences in the immune response to acute COVID-19 respiratory tract infection
Shaohua Qi, Conelius Ngwa, Diego Morales‐Scheihing, et al.
Biology of Sex Differences (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression
Swati Goel, Fatemeh Saheb Sharif‐Askari, Narjes Saheb Sharif‐Askari, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 66
In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis
Hikmat Permana, Ian Huang, Aga Purwiga, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 3, pp. 769-780
Open Access | Times Cited: 65
Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages—Potential Implications for Cytokine Storm Syndrome
Iwona Karwaciak, Anna Sałkowska, Kaja Karaś, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 54-54
Open Access | Times Cited: 64
S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes
Leah Mellett, Shabaana A. Khader
Cytokine & Growth Factor Reviews (2021) Vol. 63, pp. 90-97
Open Access | Times Cited: 64
Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 6, pp. e1009634-e1009634
Open Access | Times Cited: 60
The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
Abbas F. Almulla, Thitiporn Supasitthumrong, Chavit Tunvirachaisakul, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 60
SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages
Ioanna Pantazi, Ahmed A. Al‐Qahtani, Fatimah S. Alhamlan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 58
Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
Suwen Hu, Songwei Jiang, Qi Xiang, et al.
Drug Development Research (2021) Vol. 83, Iss. 1, pp. 16-54
Open Access | Times Cited: 58
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112419-112419
Open Access | Times Cited: 57
Consequences of COVID-19 for the Pancreas
Urszula Abramczyk, Maciej Nowaczyński, Adam Słomczyński, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 864-864
Open Access | Times Cited: 53
The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis
Ceria Halim, Audrey Fabianisa Mirza, Mutiara Indah Sari
Pathogens (2022) Vol. 11, Iss. 2, pp. 195-195
Open Access | Times Cited: 50
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro
Santosh Suryavanshi, Mariia Zaiachuk, Nazar Pryimak, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1391-1391
Open Access | Times Cited: 46
Serum Cortisol Concentration and COVID-19 Severity: A Systematic Review and Meta-Analysis
Nasrin Amiri‐Dashatan, Mehdi Koushki, Negin Parsamanesh, et al.
Journal of Investigative Medicine (2022) Vol. 70, Iss. 3, pp. 766-772
Closed Access | Times Cited: 45
Associations between Serum Interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis
Yuanmin Chang, Mengru Bai, Qinghai You
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 43
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Open Access | Times Cited: 42
In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach
Michaël Maes, Walton Luiz Del Tedesco, Marcell Alysson Batisti Lozovoy, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1945-1955
Open Access | Times Cited: 41
Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome
Meghan H. Shilts, Christian Rosas‐Salazar, Britton A. Strickland, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 40
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial
MeiLan K. Han, Martti Antila, Joachim H. Ficker, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 5, pp. e351-e361
Open Access | Times Cited: 40

Scroll to top